Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies.
- 19 July 2000
- journal article
- clinical trial
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 46 (1) , S67-S72
- https://doi.org/10.1007/pl00014053
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: